LIPID-PEROXIDATION ACCOMPANIES CYCLOSPORINE NEPHROTOXICITY - EFFECTS OF VITAMIN-E

被引:144
作者
WANG, CY [1 ]
SALAHUDEEN, AK [1 ]
机构
[1] UNIV MISSISSIPPI,MED CTR,DEPT MED,DIV RENAL,JACKSON,MS 39216
关键词
D O I
10.1038/ki.1995.138
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cyclosporine A (CsA) has been demonstrated to induce renal microsomal lipid peroxidation in vitro. To examine whether CsA induces lipid peroxidation in vivo, uninephrectomized rats were gavaged with vehicle, CsA 12.5 or 25 mg/kg/day for four weeks. CsA-induced reduction in GFR and RBF was associated with a dose-related increase in renal cortical malondialdehyde (MDA) and conjugated diene, as well as a similar increase in arterial MDA. The latter was apparent within two hours of a single intraperitoneal injection of 25 mg/kg CsA and preceded the acute fall in GFR. To address whether lipid peroxidation contributed to CsA nephrotoxicity, rats were gavaged with vehicles, CsA 25 mg/kg/day or CsA plus vitamin E 25 mg/kg/day for eight weeks. Vitamine E, a lipid radical scavenger, inhibited MDA raise and reduced CsA-induced renal damage. Conversely, CsA administration to vitamin E and selenium deficient rats was accompanied by a greater increase in arterial MDA and fall in GFR. These novel findings, that CsA nephrotoxicity is associated with lipid peroxidation and that a chain-breaking antioxidant ameliorates whereas its deficiency exacerbates, indicate a role for lipid peroxidation, presumably free radical-mediated, in CsA toxicity.
引用
收藏
页码:927 / 934
页数:8
相关论文
共 43 条
  • [1] AHMED SS, 1993, J PHARMACOL EXP THER, V265, P1047
  • [2] Aust SD, 1985, CRC HDB METHODS OXYG, P203
  • [3] STIMULATION BY OXYGEN RADICALS OF PROSTAGLANDIN PRODUCTION BY RAT RENAL GLOMERULI
    BAUD, L
    NIVEZ, MP
    CHANSEL, D
    ARDAILLOU, R
    [J]. KIDNEY INTERNATIONAL, 1981, 20 (03) : 332 - 339
  • [4] ROLE OF NITRIC-OXIDE IN RENAL HEMODYNAMIC ABNORMALITIES OF CYCLOSPORINE NEPHROTOXICITY
    BOBADILLA, NA
    TAPIA, E
    FRANCO, M
    LOPEZ, P
    MENDOZA, S
    GARCIATORRES, R
    ALVARADO, JA
    HERRERAACOSTA, J
    [J]. KIDNEY INTERNATIONAL, 1994, 46 (03) : 773 - 779
  • [5] SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1
    BORDER, WA
    OKUDA, S
    LANGUINO, LR
    SPORN, MB
    RUOSLAHTI, E
    [J]. NATURE, 1990, 346 (6282) : 371 - 374
  • [6] PARAQUAT - MODEL FOR OXIDANT-INITIATED TOXICITY
    BUS, JS
    GIBSON, JE
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1984, 55 (APR) : 37 - 46
  • [7] INCREASED LIPID-PEROXIDATION IN CYCLOSPORINE-TREATED HEART-TRANSPLANT RECIPIENTS
    CHANCERELLE, Y
    DELORGERIL, M
    VIRET, R
    CHIRON, B
    DUREAU, G
    RENAUD, S
    KERGONOU, JF
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (08) : 813 - 816
  • [8] EVIDENCE THAT RENAL PROSTAGLANDIN AND THROMBOXANE PRODUCTION IS STIMULATED IN CHRONIC CYCLOSPORINE NEPHROTOXICITY
    COFFMAN, TM
    CARR, DR
    YARGER, WE
    KLOTMAN, PE
    [J]. TRANSPLANTATION, 1987, 43 (02) : 282 - 285
  • [9] DAVIS LS, 1994, J AM SOC NEPHROL, V4, P1448
  • [10] RENAL-FUNCTION AND BLOOD-PRESSURE IN PATIENTS RECEIVING LONG-TERM, LOW-DOSE CYCLOSPORINE THERAPY FOR IDIOPATHIC AUTOIMMUNE UVEITIS
    DERAY, G
    BENHMIDA, M
    LEHOANG, P
    MAKSUD, P
    AUPETIT, B
    BAUMELOU, A
    JACOBS, C
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (07) : 578 - 583